United States Biotechnology & Medical Research

KP Pharmaceuticals LLC (KG)

Track

Ticker: KG Exchange: NYQ
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
SCHAFFER DERACE L Non-Executive Director
Transaction date
Purchase
Price
225.28
Quantity 96,103 +3.9%
Value US$4,038,904
MARKISON BRIAN A President and CEO Executive Director
Transaction date
Sale
Price
289.48
Quantity 37,614 +1.5%
Value US$4,687,357
BROUILLETTE FREDERICK JR Corporate Compliance Officer Officer
Transaction date
Sale
Price
122.18
Quantity 38,606 +32.3%
Value US$3,440,819
BROUILLETTE FREDERICK JR Corporate Compliance Officer Officer
Transaction date
Sale
Price
11.42
Quantity 6,190 -6.2%
Value US$70,690
ANDRZEJEWSKI STEPHEN J Chief Commercial Officer Officer
Transaction date
Planned sale
Price
10.07
Quantity 10,800 -7.2%
Value US$108,756
ANDRZEJEWSKI STEPHEN J Chief Commercial Officer Officer
Transaction date
Planned sale
Price
9.98
Quantity 8,500 -5.3%
Value US$84,830
ANDRZEJEWSKI STEPHEN J Chief Commercial Officer Officer
Transaction date
Planned sale
Price
10.00
Quantity 5,724 -3.5%
Value US$57,240
ANDRZEJEWSKI STEPHEN J Chief Commercial Officer Officer
Transaction date
Planned sale
Price
9.97
Quantity 3,800 -2.3%
Value US$37,886
ANDRZEJEWSKI STEPHEN J Chief Commercial Officer Officer
Transaction date
Planned sale
Price
9.99
Quantity 2,200 -1.3%
Value US$21,978
ANDRZEJEWSKI STEPHEN J Chief Commercial Officer Officer
Transaction date
Planned sale
Price
10.01
Quantity 400 -0.2%
Value US$4,004
ANDRZEJEWSKI STEPHEN J Chief Commercial Officer Officer
Transaction date
Planned sale
Price
10.05
Quantity 200 -0.1%
Value US$2,010
MOYER CHARLES Non-Executive Director
Transaction date
Planned sale
Price
15.06
Quantity 3,500 -29.3%
Value US$52,710
ROOKER D GREGORY Non-Executive Director
Transaction date
Planned sale
Price
18.73
Quantity 11,570 -100.0%
Value US$216,681
ROOKER D GREGORY Non-Executive Director
Transaction date
Planned sale
Price
18.00
Quantity 8,549 -100.0%
Value US$153,882
ROOKER D GREGORY Non-Executive Director
Transaction date
Planned sale
Price
17.40
Quantity 30,266 -45.5%
Value US$526,628
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2010-05-18 2010-05-14 B Purchase SCHAFFER DERACE L Non-Executive Director
96,103 +3.9%
225.28
US$4,038,904 		96,103 +3.9% 225.28 US$4,038,904
2010-03-04 2010-03-03 S Sale MARKISON BRIAN A

President and CEO

Executive Director
37,614 +1.5%
289.48
US$4,687,357 		37,614 +1.5% 289.48 US$4,687,357
2010-03-04 2010-03-02 S Sale BROUILLETTE FREDERICK JR

Corporate Compliance Officer

Officer
38,606 +32.3%
122.18
US$3,440,819 		38,606 +32.3% 122.18 US$3,440,819
2010-03-04 2010-03-02 S Sale BROUILLETTE FREDERICK JR

Corporate Compliance Officer

Officer
6,190 -6.2%
11.42
US$70,690 		6,190 -6.2% 11.42 US$70,690
2008-06-05 2008-06-03 PlS Planned sale ANDRZEJEWSKI STEPHEN J

Chief Commercial Officer

Officer
10,800 -7.2%
10.07
US$108,756 		10,800 -7.2% 10.07 US$108,756
2008-06-05 2008-06-03 PlS Planned sale ANDRZEJEWSKI STEPHEN J

Chief Commercial Officer

Officer
8,500 -5.3%
9.98
US$84,830 		8,500 -5.3% 9.98 US$84,830
2008-06-05 2008-06-03 PlS Planned sale ANDRZEJEWSKI STEPHEN J

Chief Commercial Officer

Officer
5,724 -3.5%
10.00
US$57,240 		5,724 -3.5% 10.00 US$57,240
2008-06-05 2008-06-03 PlS Planned sale ANDRZEJEWSKI STEPHEN J

Chief Commercial Officer

Officer
3,800 -2.3%
9.97
US$37,886 		3,800 -2.3% 9.97 US$37,886
2008-06-05 2008-06-03 PlS Planned sale ANDRZEJEWSKI STEPHEN J

Chief Commercial Officer

Officer
2,200 -1.3%
9.99
US$21,978 		2,200 -1.3% 9.99 US$21,978
2008-06-05 2008-06-03 PlS Planned sale ANDRZEJEWSKI STEPHEN J

Chief Commercial Officer

Officer
400 -0.2%
10.01
US$4,004 		400 -0.2% 10.01 US$4,004
2008-06-05 2008-06-03 PlS Planned sale ANDRZEJEWSKI STEPHEN J

Chief Commercial Officer

Officer
200 -0.1%
10.05
US$2,010 		200 -0.1% 10.05 US$2,010
2007-09-05 2007-09-04 PlS Planned sale MOYER CHARLES Non-Executive Director
3,500 -29.3%
15.06
US$52,710 		3,500 -29.3% 15.06 US$52,710
2007-03-20 2007-03-16 PlS Planned sale ROOKER D GREGORY Non-Executive Director
11,570 -100.0%
18.73
US$216,681 		11,570 -100.0% 18.73 US$216,681
2007-01-18 2007-01-16 PlS Planned sale ROOKER D GREGORY Non-Executive Director
8,549 -100.0%
18.00
US$153,882 		8,549 -100.0% 18.00 US$153,882
2007-01-18 2007-01-16 PlS Planned sale ROOKER D GREGORY Non-Executive Director
30,266 -45.5%
17.40
US$526,628 		30,266 -45.5% 17.40 US$526,628
Explore more

More insider trading research around KP Pharmaceuticals LLC

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America